1. Home
  2. GORO vs ELDN Comparison

GORO vs ELDN Comparison

Compare GORO & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gold Resource Corporation

GORO

Gold Resource Corporation

HOLD

Current Price

$0.73

Market Cap

112.3M

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.48

Market Cap

120.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GORO
ELDN
Founded
1998
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
112.3M
120.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
GORO
ELDN
Price
$0.73
$1.48
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
3
Target Price
$1.38
$11.00
AVG Volume (30 Days)
1.2M
4.0M
Earning Date
11-04-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$61,430,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$117.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$1.35
52 Week High
$1.18
$5.08

Technical Indicators

Market Signals
Indicator
GORO
ELDN
Relative Strength Index (RSI) 50.55 31.96
Support Level $0.62 $1.54
Resistance Level $0.83 $1.68
Average True Range (ATR) 0.06 0.19
MACD 0.01 -0.02
Stochastic Oscillator 52.29 22.41

Price Performance

Historical Comparison
GORO
ELDN

About GORO Gold Resource Corporation

Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: